首页 > 最新文献

Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia最新文献

英文 中文
Issue Information 问题信息
{"title":"Issue Information","authors":"","doi":"10.1002/mar.21682","DOIUrl":"https://doi.org/10.1002/mar.21682","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44506496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chapter 1: Medication Reconciliation 第一章:药物和解
{"title":"Chapter 1: Medication Reconciliation","authors":"","doi":"10.1002/j.2055-2335.2013.tb00895.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00895.x","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00895.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Chapter 8: Prioritising Clinical Pharmacy Services 第八章:优先安排临床药学服务
{"title":"Chapter 8: Prioritising Clinical Pharmacy Services","authors":"","doi":"10.1002/j.2055-2335.2013.tb00902.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00902.x","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00902.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Chapter 9: Staffing Levels and Structure for the Provision of Clinical Pharmacy Services 第九章:提供临床药学服务的人员编制及结构
{"title":"Chapter 9: Staffing Levels and Structure for the Provision of Clinical Pharmacy Services","authors":"","doi":"10.1002/j.2055-2335.2013.tb00903.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00903.x","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00903.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Chapter 4: Medication Management Plan 第四章:药物管理计划
{"title":"Chapter 4: Medication Management Plan","authors":"","doi":"10.1002/j.2055-2335.2013.tb00898.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00898.x","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00898.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Overview: Standards of Practice for Clinical Pharmacy Services 概述:临床药学服务的实践标准
G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton
SHPA Committee of Speciality Practice in Clinical Pharmacy. George Taylor (Chair), Anne Leversha, Christopher Archer, Camille Boland, Michael Dooley, Peter Fowler, Sharon Gordon-Croal, Jay Fitch, Sally Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, Karen O’Leary, Cameron Randall, Amber Roberts, Suzette Seaton Corresponding author: George Taylor, Clinical Lecturer, School of Pharmacy, University of Tasmania, Hobart Tas. 7001, Australia. E-mail: G.Taylor@utas.edu.au INTRODUCTION These standards supersede the previously published SHPA Standards of Practice for Clinical Pharmacy and SHPA Standards of Practice for the Provision of Medication Reconciliation. The practice of clinical pharmacy continues to evolve with the changing needs and demands of contemporary health care. These standards are applicable to the delivery of clinical pharmacy services across all care settings: inpatients, outpatients and patients in the community. They describe the activities delivered by pharmacists for patients to minimise the risks associated with the use of medicines and to optimise the use of medicines. Comprehensive and accountable clinical pharmacy services are an essential component of contemporary health care. Ideally, every health service organisation will have resources to provide all clinical pharmacy activities to every patient based on their needs. Australian and overseas practice-based evidence con! rm that the pharmacist activities described in these standards support an individual patient’s medication management plan (MMP) and reduce morbidity, mortality and the cost of care. Clinical pharmacy services for individual patients support the objectives of: • Guiding Principles to Achieve Continuity in Medication Management • National Safety and Quality Health Service Standards • Australian Safety and Quality Goals for Health Care • Hospital Accreditation Workbook • National Strategy for Quality Use of Medicines • Medication Safety Self-Assessment for Australian Hospitals • Antimicrobial Stewardship in Australian Hospitals. In addition, clinical pharmacy services for individual patients enable the objectives of national strategies to improve patient safety and quality of care to be met, such as: • Patient-Centred Care: Improving Quality and Safety through Partnerships with Patients and Consumers • Match Up Medicines: A Guide to Medication Reconciliation • National Inpatient Medication Chart (NIMC), National Aged Care Residential Medication Chart, Paediatric Medication Chart, Private Hospital NIMC and Private Hospital Day Surgery NIMC • National Medication Management Plan • Australian Charter of Healthcare Rights • OSSIE Guide to Clinical Handover Improvement. Other SHPA standards of practice and guidelines in specialty areas should be read in conjunction with these standards including: • Standards of Practice for Medication Safety • Standards of Practice for Drug Use Evaluation in Australian Hospitals • Standards of Practice for the
SHPA临床药学专业实践委员会。George Taylor(主席)、Anne Leversha、Christopher Archer、Camille Boland、Michael Dooley、Peter Fowler、Sharon Gordon-Croal、Jay Fitch、Sally Marotti、Amy McKenzie、Duncan McKenzie、Natalie Collard、Nicki Burridge、Karen O ' Leary、Cameron Randall、Amber Roberts、Suzette Seaton通讯作者:George Taylor,塔斯马尼亚大学药学院临床讲师,澳大利亚霍巴特塔斯7001。这些标准取代了先前发布的SHPA临床药学实践标准和SHPA药物调节提供实践标准。临床药学的实践随着当代卫生保健需求的变化而不断发展。这些标准适用于在所有护理环境中提供临床药学服务:住院病人、门诊病人和社区病人。它们描述了药剂师为患者提供的活动,以尽量减少与药物使用相关的风险并优化药物使用。全面和负责任的临床药学服务是当代卫生保健的重要组成部分。理想情况下,每个卫生服务机构都将拥有资源,根据每个患者的需要为他们提供所有临床药学活动。澳大利亚和海外基于实践的证据欺诈!这些标准中描述的药剂师活动支持单个患者的药物管理计划(MMP),并降低发病率、死亡率和护理成本。为个体患者提供的临床药学服务支持以下目标:实现药物管理连续性的指导原则;国家安全和质量卫生服务标准;澳大利亚卫生保健安全和质量目标;医院认证工作手册;药品质量使用国家战略;澳大利亚医院用药安全自我评估;澳大利亚医院抗菌药物管理。此外,针对个别患者的临床药学服务使改善患者安全和护理质量的国家战略目标得以实现,例如:以患者为中心的护理:通过与患者和消费者的伙伴关系提高质量和安全;药物调解指南·全国住院患者用药图表(NIMC)、全国老年护理住院用药图表、儿科用药图表、私立医院NIMC和私立医院日间手术NIMC·国家药物管理计划·澳大利亚医疗保健权利宪章·OSSIE临床移交改进指南。其他专业领域的SHPA实践标准和指南应与这些标准一起阅读,包括:《药物安全实践标准》《澳大利亚医院药物使用评估实践标准》《提供临床肿瘤学药学服务实践标准》《精神健康药学实践标准》《社区联络药剂师实践标准》《医院和寄宿护理机构自我用药指南》《为治疗癌症提供口服化疗的实践标准》《急诊医学药学实践标准》《医院药剂师提供消费者药品信息的实践标准》《重症监护药学实践标准》《提供姑息治疗药学服务的实践标准》《药学研究药物服务的实践标准》《药品信息服务的实践标准》。提供临床服务的药剂师在实践的各个方面的专业行为应遵循:澳大利亚药房委员会准则和指南;SHPA道德准则;澳大利亚药剂师国家能力标准框架。熟悉药物管理途径以及其他非临床医院药房服务如何支持该途径的每个步骤,有助于理解临床药学服务的背景(图1,2)。
{"title":"Overview: Standards of Practice for Clinical Pharmacy Services","authors":"G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton","doi":"10.1002/j.2055-2335.2013.tb00894.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00894.x","url":null,"abstract":"SHPA Committee of Speciality Practice in Clinical Pharmacy. George Taylor (Chair), Anne Leversha, Christopher Archer, Camille Boland, Michael Dooley, Peter Fowler, Sharon Gordon-Croal, Jay Fitch, Sally Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, Karen O’Leary, Cameron Randall, Amber Roberts, Suzette Seaton Corresponding author: George Taylor, Clinical Lecturer, School of Pharmacy, University of Tasmania, Hobart Tas. 7001, Australia. E-mail: G.Taylor@utas.edu.au INTRODUCTION These standards supersede the previously published SHPA Standards of Practice for Clinical Pharmacy and SHPA Standards of Practice for the Provision of Medication Reconciliation. The practice of clinical pharmacy continues to evolve with the changing needs and demands of contemporary health care. These standards are applicable to the delivery of clinical pharmacy services across all care settings: inpatients, outpatients and patients in the community. They describe the activities delivered by pharmacists for patients to minimise the risks associated with the use of medicines and to optimise the use of medicines. Comprehensive and accountable clinical pharmacy services are an essential component of contemporary health care. Ideally, every health service organisation will have resources to provide all clinical pharmacy activities to every patient based on their needs. Australian and overseas practice-based evidence con! rm that the pharmacist activities described in these standards support an individual patient’s medication management plan (MMP) and reduce morbidity, mortality and the cost of care. Clinical pharmacy services for individual patients support the objectives of: • Guiding Principles to Achieve Continuity in Medication Management • National Safety and Quality Health Service Standards • Australian Safety and Quality Goals for Health Care • Hospital Accreditation Workbook • National Strategy for Quality Use of Medicines • Medication Safety Self-Assessment for Australian Hospitals • Antimicrobial Stewardship in Australian Hospitals. In addition, clinical pharmacy services for individual patients enable the objectives of national strategies to improve patient safety and quality of care to be met, such as: • Patient-Centred Care: Improving Quality and Safety through Partnerships with Patients and Consumers • Match Up Medicines: A Guide to Medication Reconciliation • National Inpatient Medication Chart (NIMC), National Aged Care Residential Medication Chart, Paediatric Medication Chart, Private Hospital NIMC and Private Hospital Day Surgery NIMC • National Medication Management Plan • Australian Charter of Healthcare Rights • OSSIE Guide to Clinical Handover Improvement. Other SHPA standards of practice and guidelines in specialty areas should be read in conjunction with these standards including: • Standards of Practice for Medication Safety • Standards of Practice for Drug Use Evaluation in Australian Hospitals • Standards of Practice for the","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00894.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Chapter 3: Clinical Review, Therapeutic Drug Monitoring and Adverse Drug Reaction Management 第三章:临床回顾、治疗药物监测和药物不良反应管理
G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton
INTRODUCTION Clinical review, therapeutic drug monitoring (TDM) and adverse drug reaction (ADR) management contribute to the quality use of medicines by ensuring safe and appropriate dosage and administration of medicines, improving response to therapy and minimising medicinesrelated problems. Clinical review, TDM and ADR management commence when a patient presents or is admitted to a health service organisation and continue as routine activities throughout the episode of care in conjunction with assessment of current medication management and other clinical pharmacy activities.
临床审查、治疗药物监测(TDM)和药物不良反应(ADR)管理通过确保药物的安全和适当的剂量和给药、提高治疗反应和最大限度地减少药物相关问题,有助于提高药物的使用质量。临床审查、TDM和ADR管理在患者出现或被卫生服务机构收治时开始,并与当前药物管理和其他临床药学活动的评估一起,作为整个护理期间的常规活动继续进行。
{"title":"Chapter 3: Clinical Review, Therapeutic Drug Monitoring and Adverse Drug Reaction Management","authors":"G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton","doi":"10.1002/j.2055-2335.2013.tb00897.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00897.x","url":null,"abstract":"INTRODUCTION Clinical review, therapeutic drug monitoring (TDM) and adverse drug reaction (ADR) management contribute to the quality use of medicines by ensuring safe and appropriate dosage and administration of medicines, improving response to therapy and minimising medicinesrelated problems. Clinical review, TDM and ADR management commence when a patient presents or is admitted to a health service organisation and continue as routine activities throughout the episode of care in conjunction with assessment of current medication management and other clinical pharmacy activities.","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00897.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Chapter 2: Assessment of Current Medication Management 第二章:药物管理现状评估
INTRODUCTION Assessment of a patient’s current medication management is vital to ensure the quality use of medicines. The assessment aims to optimise the quality use of medicines and therefore patient outcomes, and to minimise medicines-related problems. To assess the patient’s current medication management, the pharmacist confi rms the safety and appropriateness of individual medication orders and the combination of medicines prescribed. This assessment is then documented in the patient’s record or the pharmacy section of the National Inpatient Medication Chart (NIMC) or equivalent. Assessment of a patient’s current medication management should not be done in isolation. It requires a systematic, in-depth assessment of current medicines in consultation with the patient taking into account: • the patient’s medication history • the patient’s medication management plan (MMP) and data from the medication administration record • a clinical review including therapeutic drug monitoring (TDM).
对患者当前用药管理进行评估对于确保药物的使用质量至关重要。评估的目的是优化药物的使用质量,从而优化患者的预后,并尽量减少与药物有关的问题。为了评估患者目前的用药管理情况,药剂师应确认其单药单和联合用药的安全性和适宜性。然后将此评估记录在患者记录或国家住院患者用药表(NIMC)的药房部分或同等内容中。对患者当前用药管理的评估不应孤立进行。它需要与患者协商,对当前药物进行系统、深入的评估,考虑到:•患者的用药史•患者的用药管理计划(MMP)和药物管理记录的数据•包括治疗药物监测(TDM)在内的临床审查。
{"title":"Chapter 2: Assessment of Current Medication Management","authors":"","doi":"10.1002/j.2055-2335.2013.tb00896.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00896.x","url":null,"abstract":"INTRODUCTION Assessment of a patient’s current medication management is vital to ensure the quality use of medicines. The assessment aims to optimise the quality use of medicines and therefore patient outcomes, and to minimise medicines-related problems. To assess the patient’s current medication management, the pharmacist confi rms the safety and appropriateness of individual medication orders and the combination of medicines prescribed. This assessment is then documented in the patient’s record or the pharmacy section of the National Inpatient Medication Chart (NIMC) or equivalent. Assessment of a patient’s current medication management should not be done in isolation. It requires a systematic, in-depth assessment of current medicines in consultation with the patient taking into account: • the patient’s medication history • the patient’s medication management plan (MMP) and data from the medication administration record • a clinical review including therapeutic drug monitoring (TDM).","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00896.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chapter 6: Facilitating Continuity of Medication Management on Transition Between Care Settings 第六章:促进护理环境过渡期间药物管理的连续性
G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton
INTRODUCTION Transfer of patients between health professionals, health service organisations and within health service organisations provides opportunity for medications errors if communication of the patient’s medicines information is incomplete or inaccurate. More than 50% of medication errors occur at transitions of care and up to one-third of these errors has the potential to cause harm. The Guiding Principles to Achieve Continuity in Medication Management have three guiding principles that relate to the continuity of medication management on transition between care settings: supply of medicines information to consumers, ongoing access to medicines and communicating medicines information. Pharmacists’ participation in the transition of patients between care settings supports these guiding principles. Pharmacist participation in facilitating discharge and transfer of care has been shown to reduce adverse outcomes and importantly to reduce hospital readmissions. When patients move between different settings there is a risk that their care will be fragmented. Poor communication of medical information at points of transition has been shown to be responsible for up to 50% of medication errors and up to 20% of adverse drug events. Omitting one or more medicines from the discharge summary exposes patients to 2.31 times the risk of re-admission to hospital. Communication and liaison with the patient/carer and other health professionals (e.g. GP, community pharmacists, other primary health professionals) facilitates the continuity of a patient’s medication management. Patients may have multiple prescribers including nonmedical prescribers. This communication may be via the patient’s discharge summary, medication management plan (MMP), electronic health record or equivalent. A key aspect of facilitating the continuity of medication management is to ensure the patient has affordable and continued access to the medicines they require to support their MMP. Ideally, an outreach or community liaison pharmacist would be available to facilitate patient transfer from hospital. See SHPA Standards of Practice for the Community Liaison Pharmacy Practice.
患者在卫生专业人员之间、卫生服务组织之间以及卫生服务组织内部的转移,如果患者的药物信息交流不完整或不准确,就有可能出现用药错误。50%以上的用药错误发生在护理的过渡阶段,其中多达三分之一的错误有可能造成伤害。《实现药物管理连续性指导原则》有三项指导原则,涉及在不同护理环境之间过渡时药物管理的连续性:向消费者提供药物信息、持续获得药物和沟通药物信息。药剂师参与患者在护理环境之间的过渡支持这些指导原则。药剂师参与促进出院和转移护理已被证明可以减少不良后果,重要的是减少再入院。当病人在不同的环境之间移动时,他们的护理可能会支离破碎。在过渡阶段,医疗信息的沟通不畅已被证明是造成高达50%的用药错误和高达20%的药物不良事件的原因。在出院总结中遗漏一种或多种药物会使患者再次住院的风险增加2.31倍。与患者/护理人员和其他卫生专业人员(如全科医生、社区药剂师、其他初级卫生专业人员)的沟通和联络有助于患者药物管理的连续性。患者可能有多个处方者,包括非医疗处方者。这种沟通可以通过病人的出院总结、药物管理计划(MMP)、电子健康记录或同等的方式进行。促进药物管理连续性的一个关键方面是确保患者能够负担得起并持续获得支持其MMP所需的药物。理想情况下,一名外联或社区联络药剂师可以方便病人从医院转院。参见SHPA社区联络药房实践标准。
{"title":"Chapter 6: Facilitating Continuity of Medication Management on Transition Between Care Settings","authors":"G. Taylor, A. Leversha, C. Archer, C. Boland, M. Dooley, P. Fowler, Sharon Gordon-Croal, J. Fitch, S. Marotti, Amy McKenzie, Duncan McKenzie, Natalie Collard, Nicki Burridge, K. O’Leary, C. Randall, A. Roberts, S. Seaton","doi":"10.1002/j.2055-2335.2013.tb00900.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00900.x","url":null,"abstract":"INTRODUCTION Transfer of patients between health professionals, health service organisations and within health service organisations provides opportunity for medications errors if communication of the patient’s medicines information is incomplete or inaccurate. More than 50% of medication errors occur at transitions of care and up to one-third of these errors has the potential to cause harm. The Guiding Principles to Achieve Continuity in Medication Management have three guiding principles that relate to the continuity of medication management on transition between care settings: supply of medicines information to consumers, ongoing access to medicines and communicating medicines information. Pharmacists’ participation in the transition of patients between care settings supports these guiding principles. Pharmacist participation in facilitating discharge and transfer of care has been shown to reduce adverse outcomes and importantly to reduce hospital readmissions. When patients move between different settings there is a risk that their care will be fragmented. Poor communication of medical information at points of transition has been shown to be responsible for up to 50% of medication errors and up to 20% of adverse drug events. Omitting one or more medicines from the discharge summary exposes patients to 2.31 times the risk of re-admission to hospital. Communication and liaison with the patient/carer and other health professionals (e.g. GP, community pharmacists, other primary health professionals) facilitates the continuity of a patient’s medication management. Patients may have multiple prescribers including nonmedical prescribers. This communication may be via the patient’s discharge summary, medication management plan (MMP), electronic health record or equivalent. A key aspect of facilitating the continuity of medication management is to ensure the patient has affordable and continued access to the medicines they require to support their MMP. Ideally, an outreach or community liaison pharmacist would be available to facilitate patient transfer from hospital. See SHPA Standards of Practice for the Community Liaison Pharmacy Practice.","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00900.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Chapter 5: Providing Medicines Information 第五章:提供药品信息
{"title":"Chapter 5: Providing Medicines Information","authors":"","doi":"10.1002/j.2055-2335.2013.tb00899.x","DOIUrl":"https://doi.org/10.1002/j.2055-2335.2013.tb00899.x","url":null,"abstract":"","PeriodicalId":73898,"journal":{"name":"Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/j.2055-2335.2013.tb00899.x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50724502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of pharmacy practice and research : official journal of the Society of Hospital Pharmacists of Australia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1